• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多变量数据分析评估热处理和不溶性聚(甲基)丙烯酸酯类型对羟丙甲纤维素基质片剂中高溶性药物溶出行为的影响。

The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.

作者信息

Kubova Katerina, Peček Daniel, Hasserová Kristýna, Doležel Petr, Pavelková Miroslava, Vyslouzil Jakub, Muselík Jan, Vetchy David

机构信息

a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.

出版信息

Pharm Dev Technol. 2017 Mar;22(2):206-217. doi: 10.1080/10837450.2016.1193191. Epub 2017 Jan 6.

DOI:10.1080/10837450.2016.1193191
PMID:28058866
Abstract

Hypromellose matrices exhibit extended burst effect immediately after contact with aqueous medium, especially when a water-soluble drug is incorporated. The objective of this study was to reduce burst effect and maintain complete dissolution of a very soluble levetiracetam over 12 h period from hypromellose K4M matrices to obtain zero-order kinetics. Desired changes were achieved by applying water dispersions of insoluble Eudragits (NE, NM, RL, RS) as a granulation liquid to the drug/microcrystalline cellulose mixture during high-shear granulation (non-thermal treated set) and consequently by thermally treating granules or final tablets (TT), respectively. Applying Eudragit water dispersions to the drug/microcrystalline cellulose mixture was recognized as an effective method of significantly reducing the burst release (25.4-33.7%) of levetiracetam in comparison with a reference sample without Eudragit. Multivariate data analysis showed that the addition of Eudragit reduced burst effect, increased fitting with zero-order kinetics, and supported matrix erosion as the supplementary mechanism to predominant diffusion. Moreover, resulting PCA sub-model revealed the addition of Eudragit RL and thermal treatment of tablets to be the most suitable method of all. For a 12 h dissolution profile, characterized by low burst effect and drug release close to 100% at the 12th hour, sample RL_TT was the most suitable.

摘要

羟丙甲纤维素基质在与水性介质接触后立即呈现出延长的突释效应,尤其是当加入水溶性药物时。本研究的目的是减少突释效应,并使极易溶的左乙拉西坦在12小时内从羟丙甲纤维素K4M基质中完全溶解,以获得零级动力学。通过在高剪切制粒过程中(非热处理组)将不溶性丙烯酸树脂(NE、NM、RL、RS)的水分散体作为制粒液应用于药物/微晶纤维素混合物中,并分别对颗粒或最终片剂进行热处理(TT),实现了预期的变化。与不含丙烯酸树脂的参比样品相比,将丙烯酸树脂水分散体应用于药物/微晶纤维素混合物被认为是显著降低左乙拉西坦突释(25.4 - 33.7%)的有效方法。多变量数据分析表明,加入丙烯酸树脂可降低突释效应,提高与零级动力学的拟合度,并支持基质溶蚀作为主要扩散之外的补充机制。此外,所得的主成分分析子模型表明,加入丙烯酸树脂RL和片剂热处理是所有方法中最合适的。对于12小时的溶出曲线,其特征为突释效应低且在第12小时药物释放接近100%,样品RL_TT是最合适的。

相似文献

1
The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.通过多变量数据分析评估热处理和不溶性聚(甲基)丙烯酸酯类型对羟丙甲纤维素基质片剂中高溶性药物溶出行为的影响。
Pharm Dev Technol. 2017 Mar;22(2):206-217. doi: 10.1080/10837450.2016.1193191. Epub 2017 Jan 6.
2
Investigation of Dissolution Behavior HPMC/Eudragit/Magnesium Aluminometasilicate Oral Matrices Based on NMR Solid-State Spectroscopy and Dynamic Characteristics of Gel Layer.基于 NMR 固态光谱和凝胶层动态特性研究 HPMC/Eudragit/硅酸镁铝的口服基质溶出行为。
AAPS PharmSciTech. 2018 Feb;19(2):681-692. doi: 10.1208/s12249-017-0870-6. Epub 2017 Oct 2.
3
Highly Soluble Drugs Directly Granulated by Water Dispersions of Insoluble Eudragit® Polymers as a Part of Hypromellose K100M Matrix Systems.高度水溶性药物直接由不溶性 Eudragit®聚合物的水分散体造粒作为羟丙甲纤维素 K100M 基质系统的一部分。
Biomed Res Int. 2019 Mar 5;2019:8043415. doi: 10.1155/2019/8043415. eCollection 2019.
4
The development of Eudragit® NM-based controlled-release matrix tablets.基于 Eudragit® NM 的控释骨架片的研制。
Medicina (Kaunas). 2012;48(4):192-202.
5
Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.聚醋酸乙烯酯和甲基丙烯酸氨酯共聚物作为非常规聚合物共混物可提高羟丙基甲基纤维素(HPMC)基质片剂的机械强度。
Int J Pharm. 2017 Jan 10;516(1-2):3-8. doi: 10.1016/j.ijpharm.2016.10.069. Epub 2016 Nov 3.
6
Film-coated matrix mini-tablets for the extended release of a water-soluble drug.用于水溶性药物缓释的薄膜包衣骨架型小片。
Drug Dev Ind Pharm. 2015 Apr;41(4):623-30. doi: 10.3109/03639045.2014.891128. Epub 2014 Feb 24.
7
A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.一种新型可挤出的羟丙甲纤维素:AFFINISOL™ HPMC HME。
AAPS PharmSciTech. 2016 Feb;17(1):106-19. doi: 10.1208/s12249-015-0395-9. Epub 2015 Sep 4.
8
Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.Eudragit(®) RS PO/RL PO 作为控释骨架材料的制粒:配方和工艺变量对颗粒和片剂功能特性的影响。
Drug Dev Ind Pharm. 2012 Oct;38(10):1240-53. doi: 10.3109/03639045.2011.645831. Epub 2012 Jan 19.
9
The performance of HPMC matrix tablets using various agglomeration manufacturing processes.使用各种团聚制造工艺的羟丙基甲基纤维素基质片剂的性能。
Drug Dev Ind Pharm. 2017 Feb;43(2):329-337. doi: 10.1080/03639045.2016.1249374. Epub 2016 Nov 6.
10
Effect of hydrophobic inclusions on polymer swelling kinetics studied by magnetic resonance imaging.通过磁共振成像研究疏水包裹体对聚合物溶胀动力学的影响。
Int J Pharm. 2016 Mar 16;500(1-2):136-43. doi: 10.1016/j.ijpharm.2016.01.023. Epub 2016 Jan 15.

引用本文的文献

1
Towards a better understanding of thermally treated polycarbophil matrix tablets for controlled release.为更好地理解用于控释的热处理聚卡波非基质片剂。
Int J Pharm X. 2021 Oct 7;3:100098. doi: 10.1016/j.ijpx.2021.100098. eCollection 2021 Dec.
2
Highly Soluble Drugs Directly Granulated by Water Dispersions of Insoluble Eudragit® Polymers as a Part of Hypromellose K100M Matrix Systems.高度水溶性药物直接由不溶性 Eudragit®聚合物的水分散体造粒作为羟丙甲纤维素 K100M 基质系统的一部分。
Biomed Res Int. 2019 Mar 5;2019:8043415. doi: 10.1155/2019/8043415. eCollection 2019.